SCOR SE (XSWX:SCR) Research & Development: CHF0 Mil (TTM As of Dec. 2025)


XSWX:SCR SCOR SE XSWX:SCR
45 GF Score
Price CHF28.46
GF Value CHF22.81
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is SCOR SE Research & Development?

SCOR SE XSWX:SCR -0.07% 45 Research & Development is CHF0 Mil as of Dec. 2025. GuruFocus rates XSWX:SCR with a GF Score™ of 45/100 and a GF Value™ of CHF22.81 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. SCOR SE's Research & Development for the three months ended in Dec. 2025 was CHF0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0 Mil.

SCOR SE  (XSWX:SCR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SCOR SE Research & Development Related Terms

SCOR SE Research & Development Historical Data

* Premium members only.

The historical data trend for SCOR SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SCOR SE Research & Development Chart

SCOR SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SCOR SE Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Dec24 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:SCR
45GF Score
SCOR SE XSWX:SCR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SCOR SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0 Mil mean?
SCOR SE (XSWX:SCR) has a Research & Development of CHF0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on SCOR SE and its competitors.
Is SCOR SE's Research & Development too high?
SCOR SE's current Research & Development is CHF0 Mil. Overall, SCOR SE has a GF Score™ of 45/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SCOR SE's Research & Development compare to RGA and EG?
SCOR SE's Research & Development of CHF0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on SCOR SE and its competitors. SCOR SE's current Research & Development is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SCOR SE stock overvalued right now?
Based on GuruFocus' analysis, SCOR SE (XSWX:SCR) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF22.81, compared to a current price of CHF28.46 — trading 24.8% above its estimated fair value. The current Research & Development is CHF0 Mil. SCOR SE's overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For SCOR SE (XSWX:SCR), the current Research & Development is CHF0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SCOR SE (XSWX:SCR) Overvalued in 2026?

Based on GuruFocus' analysis, SCOR SE stock appears to be overvalued. The current stock price of CHF28.46 is trading 24.8% above its estimated GF Value™ of CHF22.81. GuruFocus considers SCOR SE to be Modestly Overvalued.

Key valuation signals for XSWX:SCR:

  • Research & Development: CHF0 Mil
  • GF Value™: CHF22.81 vs. price of CHF28.46 (24.8% above fair value)
  • GF Score™: 45/100 with 2 warning signs

No single metric tells the full story. See the XSWX:SCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SCOR SE Business Description

Address 5, avenue Kleber, Paris, FRA, 75116
Scor is the world's sixth-largest reinsurer, selling nonlife and life reinsurance. Scor Global Life insures life, health, and annuities. This means in its co-insurance agreements Scor shares in premiums and claims of life insurance contracts that have been sold by a primary insurer. In its excess of loss agreements, Scor reimburses a primary insurer for claims that are filed above an agreed amount. Scor also sells property and casualty reinsurance in coinsurance and excess of loss. Historically, Scor has been better in specialist lines and not as good in lines where there is a large potential for loss.
45GF Score

Get the complete analysis for XSWX:SCR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF28.46
Price
CHF22.81
GF Value